PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UNC child neurologist finds potential route to better treatments for Fragile X, autism

2013-10-24
(Press-News.org) Contact information: Mark Derewicz
mark.derewicz@unch.unc.edu
919-923-0959
University of North Carolina Health Care
UNC child neurologist finds potential route to better treatments for Fragile X, autism CHAPEL HILL, N.C. – When you experience something, neurons in the brain send chemical signals called neurotransmitters across synapses to receptors on other neurons. How well that process unfolds determines how you comprehend the experience and what behaviors might follow. In people with Fragile X syndrome, a third of whom are eventually diagnosed with Autism Spectrum Disorder, that process is severely hindered, leading to intellectual impairments and abnormal behaviors.

In a study published in the online journal PLOS ONE, a team of UNC School of Medicine researchers led by neurologist C.J. Malanga, MD, PhD, describes a major reason why current medications only moderately alleviate Fragile X symptoms. Using mouse models, Malanga discovered that three specific drugs affect three different kinds of neurotransmitter receptors that all seem to play roles in Fragile X. As a result, current Fragile X drugs have limited benefit because most of them only affect one receptor.

"There likely won't be one magic bullet that really helps people with Fragile X," said Malanga, an associate professor in the Department of Neurology. "It's going to take therapies acting through different receptors to improve their behavioral symptoms and intellectual outcomes."

Nearly one million people in the United States have Fragile X Syndrome, which is the result of a single mutated gene called FMR1. In people without Fragile X, the gene produces a protein that helps maintain the proper strength of synaptic communication between neurons. In people with Fragile X, FMR1 doesn't produce the protein, the synaptic connection weakens, and there's a decrease in synaptic input, leading to mild to severe learning disabilities and behavioral issues, such as hyperactivity, anxiety, and sensitivity to sensory stimulation, especially touch and noise.

More than two decades ago, researchers discovered that – in people with mental and behavior problems – a receptor called mGluR5 could not properly regulate the effect of the neurotransmitter, glutamate. Since then, pharmaceutical companies have been trying to develop drugs that target glutamate receptors. "It's been a challenging goal," Malanga said. "No one so far has made it work very well, and kids with Fragile X have been illustrative of this."

But there are other receptors that regulate other neurotransmitters in similar ways to mGluR5. And there are drugs already available for human use that act on those receptors. So Malanga's team checked how those drugs might affect mice in which the Fragile X gene has been knocked out.

By electrically stimulating specific brain circuits, Malanga's team first learned how the mice perceived reward. The mice learned very quickly that if they press a lever, they get rewarded via a mild electrical stimulation. Then his team provided a drug molecule that acts on the same reward circuitry to see how the drugs affect the response patterns and other behaviors in the mice.

His team studied one drug that blocked dopamine receptors, another drug that blocked mGluR5 receptors, and another drug that blocked mAChR1, or M1, receptors. Three different types of neurotransmitters – dopamine, glutamate, and acetylcholine – act on those receptors. And there were big differences in how sensitive the mice were to each drug.

"Turns out, based on our study and a previous study we did with my UNC colleague Ben Philpot, that Fragile X mice and Angelman Syndrome mice are very different," Malanga said. "And how the same pharmaceuticals act in these mouse models of Autism Spectrum Disorder is very different."

Malanga's finding suggests that not all people with Fragile X share the same biological hurdles. The same is likely true, he said, for people with other autism-related disorders, such as Rett syndrome and Angelman syndrome.

"Fragile X kids likely have very different sensitivities to prescribed drugs than do other kids with different biological causes of autism," Malanga said.

INFORMATION:

The first author on Malanga's paper is post doc Eric Fish. Co-authors included graduate students Elliot Robinson and Sierra Stringfield, undergraduate Jeffrey DiBerto, and lab manager Michael Krouse. This research was funded through a Basic and Clinical Research Award from Autism Speaks.

END



ELSE PRESS RELEASES FROM THIS DATE:

Coral chemicals protect against warming oceans

2013-10-24
Coral chemicals protect against warming oceans Nature paper reveals coral animals produce the 'smell of the ocean' -- influencing cloud formation and protecting themselves against rising seawater temperatures Australian marine scientists have found the first evidence ...

Children's National researcher co-authors study on transitioning cystic fibrosis care

2013-10-24
Children's National researcher co-authors study on transitioning cystic fibrosis care Washington, DC— Children's National pediatrician and researcher, Lisa Tuchman, MD, MPH, co-authored a new study on cystic fibrosis (CF) care that found ...

Diabetes drug metformin with chemo and radiation may improve outcomes in lung cancer patients

2013-10-24
Diabetes drug metformin with chemo and radiation may improve outcomes in lung cancer patients Metformin could serve as a radiosensitizer to treat patients with stage III non-small cell lung cancer SYDNEY, AUSTRALIA—Treating aggressive ...

Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials

2013-10-24
Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials SYDNEY, AUSTRALIA— Clinical trials are key to finding new cancer treatments, but with patient participation hovering around 5 percent, ...

USC researcher learns how to break a sweat

2013-10-24
USC researcher learns how to break a sweat Without sweat, we would overheat and die. In a recent paper in the journal PLOS ONE, USC faculty member Krzysztof Kobielak and a team of researchers explored the ultimate origin of this sticky, stinky ...

New device stores electricity on silicon chips

2013-10-23
New device stores electricity on silicon chips Solar cells that produce electricity 24/7, not just when the sun is shining. Mobile phones with built-in power cells that recharge in seconds and work for weeks between charges. These are just two ...

Mount Sinai finds value and limitations of patient assistance programs for women with breast cancer

2013-10-23
Mount Sinai finds value and limitations of patient assistance programs for women with breast cancer Nearly 80 percent of women who contacted a patient assistance program had some or all of their needs met, compared with ...

Advanced light source provides a new look at vanadium dioxide

2013-10-23
Advanced light source provides a new look at vanadium dioxide Graphene may command the lion's share of attention but it is not the only material generating buzz in the electronics world. Vanadium dioxide is one of the few known materials that acts ...

Gravitational waves 'know' how black holes grow

2013-10-23
Gravitational waves 'know' how black holes grow Supermassive black holes: every large galaxy's got one. But how did they grow so big? A paper in the journal Science pits the front-running ideas about the growth of supermassive black holes against observational data — a limit ...

There's gold in them thar trees

2013-10-23
There's gold in them thar trees Eucalyptus trees - or gum trees as they are know - are drawing up gold particles from the earth via their root system and depositing it their leaves and branches. Scientists from CSIRO made the discovery and have published their findings ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] UNC child neurologist finds potential route to better treatments for Fragile X, autism